差價合約是複雜的工具,並且由於槓桿作用而具有快速虧損的高風險。 84% 的散戶投資者賬戶在與該提供商交易差價合約時虧損您應該考慮自己是否了解差價合約的運作方式,以及您是否有能力承擔損失資金的高風險。

掃碼下載 iOS 和安卓 APP

交易 Cerevel Therapeutics Holdings, Inc. - CERE CFD

26.95
0.04%
  • 概括
  • 曆史數據
  • 活動
  • 收入報表
  • 資産負債表
  • 現金流
  • 所有權
交易條件
價差 0.11
多頭倉位隔夜費用

Long position overnight fee


Margin. Your investment $1,000.00
隔夜費用 -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
來自槓桿的資金 ~ $4,000.00

前往平台
-0.024068%
空頭倉位隔夜費用

Short position overnight fee


Margin. Your investment $1,000.00
隔夜費用 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
來自槓桿的資金 ~ $4,000.00

前往平台
0.001846%
隔夜費時間 21:00 (UTC)
最小成交量 1
貨幣 USD
保證金 20%
股票交易 United States of America
交易委員會 0%

*Information provided by Capital.com

關鍵數據
前收盤價* 26.94
開盤價* 25.72
1 年變化* -4.56%
日範圍* 25.72 - 27.24
52 周範圍 19.86-41.46
平均交易量(10 天) 830.10K
平均交易量(3 個月) 12.64M
市值 3.67B
市盈率 -100.00K
流通股 156.66M
收入 N/A
EPS -2.32
股息(收益率 %) N/A
貝塔 -100.00K
下一個財報發布日期 May 8, 2023

所有數據都是由Refinitiv提供的, 除了標有星號的數據, 這是*由 Capital.com 提供的數據

  • 上週
  • 上個月
  • 去年
  • 過去兩年
  • 最大
  • 每日
  • 每週
  • 每月
日期 關閉 更改 變化 (%) 打開
Jun 29, 2022 26.95 1.81 7.20% 25.14 27.30 25.14
Jun 28, 2022 26.94 -0.93 -3.34% 27.87 29.13 26.80
Jun 27, 2022 28.99 0.89 3.17% 28.10 29.70 27.49
Jun 24, 2022 28.08 -0.17 -0.60% 28.25 29.09 27.63
Jun 23, 2022 28.54 3.28 12.98% 25.26 28.60 25.26
Jun 22, 2022 26.05 1.34 5.42% 24.71 26.24 24.71
Jun 21, 2022 25.15 -0.32 -1.26% 25.47 25.47 24.03
Jun 17, 2022 23.86 0.20 0.85% 23.66 24.42 23.16
Jun 16, 2022 22.85 -1.18 -4.91% 24.03 24.03 22.07
Jun 15, 2022 24.53 0.31 1.28% 24.22 24.87 23.33
Jun 14, 2022 24.22 0.64 2.71% 23.58 25.12 23.54
Jun 13, 2022 23.87 -0.71 -2.89% 24.58 24.67 23.20
Jun 10, 2022 25.82 -0.27 -1.03% 26.09 27.04 25.60
Jun 9, 2022 27.99 0.51 1.86% 27.48 28.92 27.48
Jun 8, 2022 28.49 1.30 4.78% 27.19 29.41 27.19
Jun 7, 2022 28.72 3.24 12.72% 25.48 28.84 25.48
Jun 6, 2022 25.86 -1.88 -6.78% 27.74 28.32 25.13
Jun 3, 2022 27.78 1.02 3.81% 26.76 28.51 26.76
Jun 2, 2022 26.98 1.06 4.09% 25.92 27.80 25.30
Jun 1, 2022 26.37 0.40 1.54% 25.97 26.76 25.02

Cerevel Therapeutics Holdings, Inc. Events

时间(协调世界时) (UTC) 国家 事件
No events scheduled
查看所有活动
  • 年度
  • 每季度
2021 2020 2019
總收入 0 0 0
營業收入 -220.098 -149.116 0
攤薄調整 0
攤薄淨收入 -225.334 -148.271 0
總營業費用 220.098 149.116
銷售/一般/行政費用,總計 58.243 45.813
研究與開發 161.855 103.303
利息收入(費用),非經營淨值 0.157 0.224
其他,淨值 -5.393 -3.274
稅前淨收入 -225.334 -152.166
稅後淨收入 -225.334 -152.142
未計算非常項目前的淨收益 -225.334 -152.142
淨收入 -225.334 -152.142
Total Adjustments to Net Income 0 3.871
普通股股東可獲收益 (不含非經常性項目) -225.334 -148.271
普通股股東可獲收益 (含非經常性項目) -225.334 -148.271
攤薄後加權平均股 136.577 73.6433
扣除特別項目的每股攤薄盈利 -1.64987 -2.01337
每股正常攤薄盈利 -1.64987 -2.01337
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
總收入 0 0 0 0 0
總營業費用 72.53 64.49 54.527 50.51 50.571
銷售/一般/行政費用,總計 17.507 16.649 14.368 13.216 14.01
研究與開發 55.023 47.841 40.159 37.294 36.561
營業收入 -72.53 -64.49 -54.527 -50.51 -50.571
利息收入(費用),非經營淨值 0.295 0.119 0.013 0.01 0.015
其他,淨值 3.941 5.316 -7.545 -2.739 -0.425
稅前淨收入 -68.294 -59.055 -62.059 -53.239 -50.981
稅後淨收入 -68.294 -59.055 -62.059 -53.239 -50.981
未計算非常項目前的淨收益 -68.294 -59.055 -62.059 -53.239 -50.981
淨收入 -68.294 -59.055 -62.059 -53.239 -50.981
普通股股東可獲收益 (不含非經常性項目) -68.294 -59.055 -62.059 -53.239 -50.981
普通股股東可獲收益 (含非經常性項目) -68.294 -59.055 -62.059 -53.239 -50.981
攤薄淨收入 -68.294 -59.055 -62.059 -53.239 -50.981
攤薄後加權平均股 147.985 147.392 144.022 127.482 127.226
扣除特別項目的每股攤薄盈利 -0.46149 -0.40067 -0.4309 -0.41762 -0.40071
Dividends per Share - Common Stock Primary Issue 0 0 0 0
每股正常攤薄盈利 -0.46149 -0.40067 -0.4309 -0.41762 -0.40071
  • 年度
  • 每季度
2021 2020 2019
流動資産總額 578.017 390.56
現金和短期投資 565.688 383.623
現金等價物 193.018 383.623
Prepaid Expenses 11.6 6.777
Other Current Assets, Total 0.729 0.16
Total Assets 688.919 445.273
Property/Plant/Equipment, Total - Net 51.7 48.624
Property/Plant/Equipment, Total - Gross 54.266 48.706
Accumulated Depreciation, Total -2.566 -0.082
Other Long Term Assets, Total 6.933 6.089
Total Current Liabilities 42.538 29.548
Accounts Payable 11.298 4.993
Accrued Expenses 30.865 24.282
Notes Payable/Short Term Debt 0 0
Other Current Liabilities, Total 0.375 0.273
Total Liabilities 110.19 60.753
Total Long Term Debt 33.54 0
Other Liabilities, Total 34.112 31.205
Total Equity 578.729 384.52
Common Stock 0.015 0.013
Additional Paid-In Capital 1195.94 775.417
Retained Earnings (Accumulated Deficit) -616.244 -390.91
Total Liabilities & Shareholders’ Equity 688.919 445.273
Total Common Shares Outstanding 147.72 127.124
短期投資 372.67
Long Term Investments 52.269
Long Term Debt 33.54
Other Equity, Total -0.986
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
流動資産總額 553.55 578.017 675.029 331.782 349.811
現金和短期投資 542.944 565.688 669.676 327.06 343.287
現金等價物 91.764 193.018 669.676 327.06 343.287
Prepaid Expenses 10.004 11.6 5.257 4.597 6.362
Other Current Assets, Total 0.602 0.729 0.096 0.125 0.162
Total Assets 618.552 688.919 733.48 391.004 408.104
Property/Plant/Equipment, Total - Net 52.663 51.7 51.98 51.92 51.784
Property/Plant/Equipment, Total - Gross 56.299 54.266 53.526 52.552 51.876
Accumulated Depreciation, Total -3.636 -2.566 -1.546 -0.632 -0.092
Other Long Term Assets, Total 4.411 6.933 6.471 7.302 6.509
Total Current Liabilities 35.318 42.538 30.8 29.257 34.151
Accounts Payable 8.183 11.298 5.445 4.986 7.755
Accrued Expenses 26.442 30.865 24.928 23.939 26.241
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 0.693 0.375 0.427 0.332 0.155
Total Liabilities 97.053 110.19 104.4 97.117 68.068
Total Long Term Debt 28.324 33.54 38.612 32.242 0
Other Liabilities, Total 33.411 34.112 34.988 35.618 33.917
Total Equity 521.499 578.729 629.08 293.887 340.036
Common Stock 0.015 0.015 0.015 0.013 0.013
Additional Paid-In Capital 1207.36 1195.94 1186.79 789.004 781.914
Retained Earnings (Accumulated Deficit) -684.538 -616.244 -557.189 -495.13 -441.891
Total Liabilities & Shareholders’ Equity 618.552 688.919 733.48 391.004 408.104
Total Common Shares Outstanding 148.183 147.72 147.136 127.585 127.325
Long Term Debt 28.324 33.54 38.612 32.242
Other Equity, Total -1.334 -0.986 -0.533
短期投資 451.18 372.67
Long Term Investments 7.928 52.269
  • 年度
  • 每季度
2021 2020 2019
淨收入/起跑線 -225.334 -152.142
經營活動産生的現金 -178.546 -117.802
經營活動産生的現金 2.731 0.397
非現金物品 28.516 16.236
營運資金的變化 15.541 17.707
投資活動産生的現金 -435.661 -18.892
資本支出 -10.503 -18.892
融資活動産生的現金 423.602 440.835
融資現金流項目 -0.355 440.835
現金淨變化 -190.605 304.141
其他投資現金流量項目,總計 -425.158
股票的發行(報廢),淨額 392.707
債務的發行(退還),淨額 31.25
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -68.294 -225.334 -166.279 -104.22 -50.981
Cash From Operating Activities -67.648 -178.546 -125.802 -82.026 -36.418
Cash From Operating Activities 1.118 2.731 1.644 0.664 0.063
Non-Cash Items 4.935 28.516 27.551 14.084 6.377
Changes in Working Capital -5.407 15.541 11.282 7.446 8.123
Cash From Investing Activities -38.542 -435.661 -9.431 -8.243 -4.66
Capital Expenditures -2.197 -10.503 -9.431 -8.243 -4.66
Cash From Financing Activities 2.603 423.602 421.286 33.706 0.742
Issuance (Retirement) of Stock, Net 2.854 392.707 390.036 2.571 0.742
Net Change in Cash -103.587 -190.605 286.053 -56.563 -40.336
Financing Cash Flow Items -0.251 -0.355 0 -0.115
Issuance (Retirement) of Debt, Net 31.25 31.25 31.25
Other Investing Cash Flow Items, Total -36.345 -425.158
投資者名稱 投資者類型 流通股百分比 持有股份 股份變動 持有日期 換手率
Bain Capital Private Equity, LP Private Equity 38.704 60632356 0 2022-12-31 LOW
Pfizer Inc Corporation 17.4581 27349211 0 2022-08-16 MED
Fidelity Management & Research Company LLC Investment Advisor 14.5879 22852917 67107 2022-12-31 LOW
Perceptive Advisors LLC Private Equity 4.1567 6511727 0 2022-12-31 MED
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 3.8476 6027510 164460 2022-12-31 LOW
T. Rowe Price Associates, Inc. Investment Advisor 3.027 4742044 1202 2022-12-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 2.2049 3454078 288570 2022-12-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 2.1858 3424220 704948 2022-12-31 LOW
Federated Hermes Global Investment Management Corp. Investment Advisor/Hedge Fund 1.8304 2867451 -445882 2022-12-31 LOW
Rock Springs Capital Management LP Hedge Fund 1.6 2506464 7316 2022-12-31 LOW
T. Rowe Price Investment Management, Inc. Investment Advisor 1.2806 2006068 4631 2022-12-31 MED
Invus Public Equities Advisors, LLC Investment Advisor 1.2128 1900000 -100000 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.7686 1204108 69847 2022-12-31 LOW
Janus Henderson Investors Investment Advisor/Hedge Fund 0.7349 1151321 -231639 2022-12-31 LOW
Lord, Abbett & Co. LLC Investment Advisor 0.7159 1121566 35610 2022-12-31 MED
Hood River Capital Management LLC Investment Advisor 0.5896 923638 27066 2022-12-31 MED
Alkeon Capital Management LLC Investment Advisor/Hedge Fund 0.5716 895509 -87899 2022-12-31 LOW
BlackRock Financial Management, Inc. Investment Advisor/Hedge Fund 0.4755 744853 7881 2022-12-31 LOW
Novalis LifeSciences LLC Private Equity 0.4043 633350 0 2022-03-31
Fidelity Institutional Asset Management Investment Advisor 0.3602 564215 34460 2022-12-31 LOW

為什麼選擇Capital.com?我們用表現來證明自己。

Capital.com Group

500K+

貿易商

92K+

每月活躍客戶

$53M+

每月投資額

$30M+

每月提取

差價合約交易計算器

如果您在特定日期(選取一個日期)開立差價合約交易並在不同日期(選取一個日期)關閉交易,計算您的假設盈虧。

交易佣金
0
  • 1:1
槓桿
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
投資
交易規模(槓桿 x 投資):
打開

關閉

做空 做多
Industry: Bio Therapeutic Drugs

222 Jacobs Street
Suite 200
CAMBRIDGE
MASSACHUSETTS 02141
US

收入報表

  • Annual
  • Quarterly

人們也觀看

BTC/USD

27,825.45 Price
+1.490% 1D Chg, %
多頭倉位隔夜費用 -0.0616%
空頭倉位隔夜費用 0.0137%
隔夜費時間 21:00 (UTC)
價差 60.00

US100

12,798.80 Price
+0.420% 1D Chg, %
多頭倉位隔夜費用 -0.0241%
空頭倉位隔夜費用 0.0018%
隔夜費時間 21:00 (UTC)
價差 3.0

Gold

1,978.85 Price
-0.760% 1D Chg, %
多頭倉位隔夜費用 -0.0179%
空頭倉位隔夜費用 0.0097%
隔夜費時間 21:00 (UTC)
價差 0.30

Oil - Crude

69.28 Price
-0.330% 1D Chg, %
多頭倉位隔夜費用 -0.0194%
空頭倉位隔夜費用 -0.0025%
隔夜費時間 21:00 (UTC)
價差 0.03

還在尋找值得信賴的經紀商?

加入全球 500.000 多名交易者,選擇與 Capital.com 交易

1. 建立並驗證您的賬戶 2. 存入您的第一筆資金 3. 您已準備就緒。開始交易